相关实验视频
Updated: Jul 12, 2025

07:32
Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
4.1K
肠道微生物群和高血压:对最近的研究 (2014-2023) 的文献分析
Yang Jiao1, Wenxing Li1,2, Qianyi Zhang1,2
1Department of Cardiology, Zunyi First People's Hospital, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Frontiers in nutrition
|October 30, 2023
概括
研究表明,肠道微生物群 (GM) 与高血压 (HTN) 之间的联系越来越大. 本文献分析突出了关键的研究领域和趋势,以了解这种关系的心血管健康.
科学领域:
- 心血管研究研究心血管研究
- 微生物组科学 微生物组科学
- 图书统计学 图书统计学
背景情况:
- 高血压 (HTN) 是心血管疾病的主要全球风险因素.
- 肠道微生物群 (GM) 越来越多地被认为具有治疗心血管疾病的潜力,包括HTN.
- 了解GM和HTN之间的复杂联系对于推进心血管健康研究至关重要.
研究的目的:
- 进行对肠道微生物群和高血压研究的文献分析.
- 确定关键的研究领域,有影响力的作者,以及该领域的新兴趋势.
- 为未来的科学参考提供主要研究方向的客观总结.
主要方法:
- 对2014年至2023年间发表的1,730篇文章进行了图书统计分析.
- 利用Web of Science数据库进行文章检索.
- 使用CiteSpace和VOSviewer软件进行数据分析.
主要成果:
- 肠道微生物群和高血压研究领域在2014-2023年间显著增长.
- 中国在出版量方面处于领先地位,而美国在国际合作方面处于领先地位.
- 关键的研究主题包括代谢综合征,炎症,短链脂肪酸和三甲基胺N-氧化物.
结论:
- 肠道微生物群和高血压之间的关系是一个充满活力和不断扩大的研究领域.
- 图书计量分析揭示了核心研究方向和有影响力的贡献.
- 这项研究为GM和HTN的研究人员提供了对当前热点和未来趋势的见解.
更多相关视频
相关概念视频
Hypertension III: Clinical Manifestations and Diagnostic Studies
15
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
15
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hypertension II: Pathophysiology
14
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
14
Hypertension I: Introduction
14
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
14
Factors affecting Blood pressure
3.2K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
3.2K
Hypertension IV: Drug Therapy and Lifestyle Modifications
12
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
12

